Cirrhosis News and Research

Latest Cirrhosis News and Research

Anti-hepatitis treatment also helps improve later complications

Hepatitis C is a serious disease, but the biggest threat to someone's health is not the virus itself. Rather, it is the diseases that can result from it such as reduced liver functioning, scar tissue in the liver and potentially cirrhosis.

5 Dec 2019

Researchers create 3D liver model for improved diagnosis of non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease is becoming the most common chronic liver disorder in developed countries. Histological analysis of liver tissue is the only widely accepted test for diagnosing and distinguishing different stages of the disease. However, this technique provides only two-dimensional images of the liver tissue in low resolution and overlooks potentially important 3D structural changes.

4 Dec 2019

Updated website reflects major developments in identification, management of chronic hepatitis C

A website developed by the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America to provide up-to-date guidance on the management of hepatitis C was recently revised to reflect important developments in the identification and management of chronic hepatitis C (HCV).

4 Dec 2019

Life expectancy in the United States steadily decreasing

Life expectancy in the United States is decreasing, and it may be due to the increasing rates of drug abuse and suicide, a new study finds.

27 Nov 2019

Study shows how drinking patterns reprogram circadian metabolism in the liver

Drinking alcohol is a widespread habit in modern society and can have serious metabolic consequences. Recent studies have uncovered the interplay between nutrition, metabolism and circadian rhythms. But, until now, little has been done to understand the effects of alcohol consumption on circadian metabolism.

22 Nov 2019

Ammonia levels do not guide clinical management of hepatic encephalopathy in cirrhotic patients

The liver performs several critical functions including filtering blood, detoxifying chemicals and metabolizing drugs.

19 Nov 2019

Study finds lower levels of liver decompensation in pregnant women with cirrhosis

Data from a new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases and funded by the AASLD Foundation – found that less than two percent of pregnant women with cirrhosis had liver decompensation within one year of delivery, and their odds of decompensation is much lower than non-pregnant women with cirrhosis.

10 Nov 2019

HCC and cirrhosis-related deaths may be prevented by lifestyle modifications

Data from a new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that a substantial burden of hepatocellular carcinoma and cirrhosis-related deaths may be prevented by lifestyle modifications to diet, alcohol use and exercise.

10 Nov 2019

Natural language processing helps evaluate electronic messages from ESLD patients

Natural language processing, the technology that lets computers read, decipher, understand and make sense of human language, is the driving force behind internet search engines, email filters, digital assistants such as Amazon's Alexa and Apple's Siri, and language-to-language translation apps.

From Johns Hopkins Medicine 7 Nov 2019

Deaths from liver cancer increased 3-fold over 20 years in England

Liver cancer is rapidly moving up the cancer killer ranks in England, according to a new study that is to be presented at the 201th NCRI Cancer Conference on November 2, 2019. Both the number of new cases and the mortality rate from hepatocellular carcinoma (HCC), have tripled, over the period from 1997 to 2016. HCC is the most common form of liver cancer. Moreover, a quarter of these cases occur among the least privileged fifth of society.

3 Nov 2019

Proton radiation therapy can help treat patients with hepatocellular carcinoma

Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma (HCC), a common but often fatal type of liver cancer for which there are limited treatment options. One study (Sanford et al.) suggests that proton radiation, compared to traditional photon radiation, can extend overall survival with reduced toxicity.

30 Oct 2019

New contrast agent improves MRI diagnosis of early liver fibrosis

A new compound has been invented to bind to liver cells that are in the early stages of damage, thus making it easier to pick them up using MRI (magnetic resonance imaging).

30 Oct 2019

New way to slow and reverse fibrosis identified

In cell and mouse models, Mayo Clinic researchers and collaborators have identified a way to slow and reverse the process of uncontrolled internal scarring, called fibrosis.

30 Oct 2019

Studies support use of proton radiation therapy to treat patients with fatal type of liver cancer

Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma, a common but often fatal type of liver cancer for which there are limited treatment options.

30 Oct 2019

MRI contrast agent enables early detection of liver disease

Researchers have developed a new MRI contrast dye that enables more accurate and safer detection of early-stage liver disease than currently approved agents.

30 Oct 2019

Cleveland Clinic successfully performs first laparoscopic living donor liver transplantation

Cleveland Clinic has successfully performed the Midwest's first purely laparoscopic living donor surgery for liver transplantation in an adult recipient.

30 Oct 2019

IU researcher receives NIH grant to perform clinical trial on cirrhosis

An Indiana University School of Medicine researcher has been awarded a five-year, $1.8 million grant from the National Institutes of Health for a clinical trial, aimed at providing new avenues to improve liver function for patients with alcoholic cirrhosis.

30 Oct 2019

First effective noninvasive method for diagnosing early-stage liver diseases

A safer and more sensitive contrast dye for MRI tests developed by a team led by Georgia State University researchers may provide the first effective, noninvasive method for detecting and diagnosing early-stage liver diseases, including liver fibrosis.

29 Oct 2019

New diagnostic technique enables grading of tumor consistency using MRI

Researchers from Charité - Universitätsmedizin Berlin have developed a new diagnostic technique which enables the grading of tumor consistency using magnetic resonance imaging (MRI). The researchers used an imaging technique known as tomoelastography to visualize the mechanical properties of liver tumors.

28 Oct 2019

Pharma sells states on ‘Netflix model’ to wipe out hep C. But at what price?

When a long, black bus bearing the logo of drugmaker AbbVie rolls through Washington state next year, it will promote a new effort to eradicate hepatitis C infections.

25 Oct 2019

Cirrhosis News and Research

Latest Cirrhosis News and Research

Anti-hepatitis treatment also helps improve later complications

Researchers create 3D liver model for improved diagnosis of non-alcoholic fatty liver disease

Updated website reflects major developments in identification, management of chronic hepatitis C

Life expectancy in the United States steadily decreasing

Study shows how drinking patterns reprogram circadian metabolism in the liver

Ammonia levels do not guide clinical management of hepatic encephalopathy in cirrhotic patients

Study finds lower levels of liver decompensation in pregnant women with cirrhosis

HCC and cirrhosis-related deaths may be prevented by lifestyle modifications

Natural language processing helps evaluate electronic messages from ESLD patients

Deaths from liver cancer increased 3-fold over 20 years in England

Proton radiation therapy can help treat patients with hepatocellular carcinoma

New contrast agent improves MRI diagnosis of early liver fibrosis

New way to slow and reverse fibrosis identified

Studies support use of proton radiation therapy to treat patients with fatal type of liver cancer

MRI contrast agent enables early detection of liver disease

Cleveland Clinic successfully performs first laparoscopic living donor liver transplantation

IU researcher receives NIH grant to perform clinical trial on cirrhosis

First effective noninvasive method for diagnosing early-stage liver diseases

New diagnostic technique enables grading of tumor consistency using MRI

Pharma sells states on ‘Netflix model’ to wipe out hep C. But at what price?

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Cirrhosis News and Research

Latest Cirrhosis News and Research

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in